review · Annals of Medicine and Surgery
Global efforts against HIV and AIDS face persistent challenges due to uncertain and insufficient funding, despite notable progress in prevention and medical treatments. In 2023, approximately 37.7 million people were living with HIV globally, alongside 1.5 million new infections annually, with sub-Saharan Africa carrying 67 percent of the total burden. Financial fluctuations directly undermine access to treatment, the delivery of prevention programmes, and research activities. Addressing these ongoing resource gaps requires adopting diversified and innovative financing mechanisms. Evaluated strategies such as public-private partnerships and social impact bonds provide practical frameworks for stabilising investment. Coordinating sustainable financing pathways among policymakers and international stakeholders remains essential to preserve hard-won medical gains, widen access to care, and work towards an AIDS-free generation.
Funding instability threatens decades of progress in combating HIV, especially in heavily affected regions such as sub-Saharan Africa. Identifying sustainable financing mechanisms helps healthcare systems, policymakers, and international partners maintain uninterrupted access to life-saving treatments, deliver essential prevention programmes, and avoid reversals in public health gains caused by sudden financial shortfalls.
The findings highlight policy and financing instruments rather than a direct commercial product. The identified models, specifically public-private partnerships and social impact bonds, offer applied mechanisms for private investors, commercial organisations, and public health entities to structure collaborative investments. These frameworks are already in active use and can be deployed by stakeholders to mobilise capital for healthcare programmes and services.
AI-generated from the published abstract. Always read the original work before citing.
The fight against human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has made significant progress over the past decades, yet sustainable funding remains a critical challenge. Despite advances in medical treatments and prevention methods, the financial resources needed to combat the epidemic consistently face uncertainties and shortfalls. As of 2023, approximately 37.7 million people are living with HIV/AIDS globally, with 1.5 million new infections reported annually. Sub-Saharan Africa remains the hardest-hit region, accounting for 67% of the global HIV burden. This paper examines the current state of HIV/AIDS funding, identifying key gaps and challenges in maintaining adequate financial resources. It highlights the effects of funding fluctuations on treatment accessibility, prevention programs, and research, stressing the urgent need for diversified and innovative financing mechanisms. The paper offers actionable insights into sustainable funding strategies by analyzing successful models such as public-private partnerships and social impact bonds. This review aims to inform policymakers, stakeholders, and the global community about the financial barriers to HIV/AIDS management and advocate for coordinated efforts to secure stable funding pathways. Ensuring consistent financial support is vital to preserving hard-won progress, expanding access to care, and achieving the ultimate goal of an AIDS-free generation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1097/ms9.0000000000002976
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
